Unknown

Dataset Information

0

Novel PSMA targeting alpha-emitting radioligand [<sup>211</sup>At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer.

ABSTRACT:

SUBMITTER: Hvass L 

PROVIDER: S-EPMC12917014 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Novel PSMA targeting alpha-emitting radioligand [&lt;sup&gt;211&lt;/sup&gt;At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer.

Hvass Lars L   Müller Marius M   Shalgunov Vladimir V   Clausen Anne S AS   Poulie Christian B M CBM   Aneheim Emma E   Jensen Holger J HJ   Herth Matthias M MM   Kjaer Andreas A  

EJNMMI research 20260127 1

Similar Datasets

Unknown PSMA PET/CT in biochemical recurrence of prostate cancer with PSA levels ≤ 0.2 ng/mL: a German multicenter analysis of conventional PSMA tracers, including [&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-PSMA-11, [&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-PSMA I&amp;T, and [&lt;sup&gt;18&lt;/sup&gt;F]PSMA-1007.
| S-EPMC12491085 | biostudies-literature
Unknown Pharmacokinetics and dosimetry of [&lt;sup&gt;177&lt;/sup&gt;Lu]Lu-PSMA-617 and [&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-PSMA-11 in Japanese patients with PSMA-positive mCRPC.
| S-EPMC12559119 | biostudies-literature
Unknown Combination of PSMA targeting alpha-emitting radioligand [&lt;sup&gt;212&lt;/sup&gt;Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer models.
| S-EPMC12283873 | biostudies-literature
Unknown Evaluation of Cyclotron Solid Target Produced Gallium-68 Chloride for the Labeling of [&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-PSMA-11 and [&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-DOTATOC.
| S-EPMC12430084 | biostudies-literature
Unknown Comparison of &lt;sup&gt;18&lt;/sup&gt;F-based PSMA radiotracers with [&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer-a systematic review and meta-analysis.
| S-EPMC11543591 | biostudies-literature
Unknown A comparison of routine [&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-PSMA-11 preparation using Locametz and Illuccix kits.
| S-EPMC11655735 | biostudies-literature
Unknown Baseline [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT before [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions.
| S-EPMC9857048 | biostudies-literature
Unknown Rapid Concentration of Ga-68 and Proof-of-Concept Microscale Labeling of [&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-PSMA-11 in a Droplet Reactor.
| S-EPMC11477945 | biostudies-literature
Unknown [&lt;sup&gt;161&lt;/sup&gt;Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [&lt;sup&gt;177&lt;/sup&gt;Lu]Lu-PSMA-617.
| S-EPMC10945337 | biostudies-literature
Unknown Evaluation of Targeted Alpha Therapy Using [&lt;sup&gt;211&lt;/sup&gt;At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models.
| S-EPMC11547022 | biostudies-literature